Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tecogen (TGEN) Liabilities and Shareholders Equity (2016 - 2025)

Tecogen (TGEN) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $41.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 50.89% year-over-year to $41.5 million, compared with a TTM value of $130.6 million through Sep 2025, up 17.81%, and an annual FY2024 reading of $31.1 million, up 11.87% over the prior year.
  • Liabilities and Shareholders Equity was $41.5 million for Q3 2025 at Tecogen, up from $28.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $41.5 million in Q3 2025 and bottomed at $27.2 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $30.4 million, with a median of $29.8 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity dropped 17.83% in 2021, then skyrocketed 50.89% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $32.4 million in 2021, then dropped by 12.7% to $28.3 million in 2022, then fell by 1.63% to $27.8 million in 2023, then rose by 11.87% to $31.1 million in 2024, then surged by 33.36% to $41.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for TGEN at $41.5 million in Q3 2025, $28.4 million in Q2 2025, and $29.7 million in Q1 2025.